# US 2001/0042255 A1 · Production of biofilaments in transgenic animals

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2001/0042255 A1
- Document ID: US20010042255A1
- Status: Published application
- Kind: A1
- Application number: 09/040,518
- Filed: 1998-03-17
- Published: 2001-11-15
- Earliest claimed: 1998-03-17
- Assignees: Nexia Biotechnologies, Inc.
- Inventors: COSTAS N. KARATZAS; JEFFREY D. TURNER; ANTHOULA LAZARIS KARATZAS
- Web page: https://patentgrep.com/patent/US20010042255A1

## CPC

- C12N 15/8509: {for producing genetically modified animals, e.g. transgenic}
- C07K 14/43518: {from spiders}
- A01K 2207/15: Humanized animals
- A01K 2217/00: Genetically modified animals
- A01K 2217/05: Animals comprising random inserted nucleic acids (transgenic)
- A01K 2227/10: Mammal
- A01K 2267/01: Animal expressing industrially exogenous proteins
- C07K 2319/00: Fusion polypeptide
- C12N 2830/008: cell type or tissue specific enhancer/promoter combination
- C12N 2830/40: being an insulator
- C12N 2830/42: being an intron or intervening sequence for splicing and/or stability of RNA
- C12N 2830/85: mammalian
- C12N 2840/20: translation of more than one cistron
- C12N 2840/203: having an IRES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A01K: ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS

## Abstract

Disclosed is a method for the recombinant production of biofilaments, such as spider silk or insect fibroins, using transgenic animals which secrete the biofilaments in their milk and/or urine, and transgenic cells which secrete the biofilaments into culture media. Such a method is useful for producing large quantities of biofilament material. Also disclosed is a nucleic acid molecule for generating such transgenic animals.

## Claims

### Claim 1

A nucleic acid molecule comprising (i) a nucleic acid sequence encoding a biofilament, (ii) a promoter that directs expression of a polypeptide in milk-producing cells or urine-producing cells, said promoter operably linked to said sequence, and (iii) a leader sequence that enables secretion of said biofilament by said milk-producing cells or said urine-producing cells, into, milk or urine, respectively, of a mammal.

### Claim 2 (depends on 1)

A mammalian embryo whose nucleus comprises the nucleic acid molecule of claim 1.

### Claim 3 (depends on 1)

A female mammal in which the genome of the mammary tissue of said female mammal comprises the nucleic acid molecule of claim 1, wherein said promoter is milk-producing cell-specific.

### Claim 4 (depends on 3)

The mammal of claim 3, wherein said mammal is a selected from the group consisting of a rodent, a ruminant, and a goat.

### Claim 5 (depends on 1)

An animal in which the genome of cells that contribute to urine production in said animal comprises the nucleic acid molecule of claim 1, wherein said promoter is urine-producing cell-specific.

### Claim 6 (depends on 5)

The animal of claim 5, wherein said animal is a mammal.

### Claim 7 (depends on 1)

The nucleic acid molecule of claim 1, wherein said biofilament is spider silk.

### Claim 8 (depends on 7)

The nucleic acid molecule of claim 7, wherein said spider silk is dragline silk.

### Claim 9 (depends on 1)

The nucleic acid molecule of claim 1, wherein said biofilament, when secreted such that the secretion is subjected to shear forces and mechanical extension, has a poly-alanine segment that undergoes a helix to a β-sheet transition, said transition forming a β-crystal that stabilizes the structure of said biofilament.

### Claim 10 (depends on 1)

The nucleic acid molecule of claim 1, wherein said biofilament has an amorphous domain that forms a β-pleated sheet such that inter-β sheet spacings are between 3 angstroms and 8 angstroms in size.

### Claim 11 (depends on 1)

The nucleic acid molecule of claim 1, wherein said biofilament has a C-terminal amino acid motif comprising an amorphous domain and a crystal forming domain, said motif having a sequence that is at least 50% identical to SEQ ID NO: 2.

### Claim 12 (depends on 1)

The nucleic acid molecule of claim 1, wherein said biofilament has a consensus sequence that is at least 50% identical to SEQ ID NO: 3.

### Claim 13

A method for producing a biofilament, said method comprising the steps of:
(a) providing an embryonal cell transfected with a biofilament encoding nucleic acid molecule that expresses and causes secretion of said biofilament from a cell derived from said transfected embryonal cell;
(b) growing said embryonal cell to produce an animal comprising biofilament expressing and secreting cells; and
(c) isolating said biofilament from said biofilament expressing and secreting cells from said animal.

### Claim 14

A method for producing a biofilament, said method comprising the steps of:
(a) providing an animal cell transfected with a nucleic acid molecule that contains (i) a nucleic acid sequence encoding a biofilament, (ii) a promoter that directs expression of a polypeptide in an animal cell, and (iii) a leader sequence that causes secretion of said biofilament by said cell;
(b) culturing said transfected cell; and
(c) isolating said biofilament from the culture medium of said cultured transfected cell.

### Claim 15 (depends on 13, 14)

The method of claim 13 or 14, wherein said biofilament is spider silk.

### Claim 16 (depends on 15)

The method of claim 15, wherein said spider silk is dragline silk.

### Claim 17 (depends on 13, 14)

The method of claim 13 or 14, wherein said biofilament, when secreted such that the secretion is subjected to shear forces and mechanical extension, has a poly-alanine segment that undergoes a helix to a β-sheet transition, said transition forming a β-crystal that stabilizes the structure of said biofilament.

### Claim 18 (depends on 13, 14)

The method of claim 13 or 14, wherein said biofilament has an amorphous domain that forms a β-pleated sheet such that inter-β sheet spacings are between 3 angstroms and 8 angstroms in size.

### Claim 19 (depends on 13, 14)

The method of claim 13 or 14, wherein said biofilament has a C-terminal amino acid motif comprising an amorphous domain and a crystal forming domain, said motif having a sequence that is at least 50% identical to SEQ ID NO: 2.

### Claim 20 (depends on 13, 14)

The method of claim 13 or 14, wherein said biofilament has a consensus sequence that is at least 50% identical to SEQ ID NO: 3.

### Claim 21 (depends on 13, 14)

The method of claim 13 or 14, wherein said animal is a mammal.
